Monument Therapeutics Alternatives & Competitors
12 companies similar to Monument Therapeutics — Bringing Precision Medicine to Neuroscience Drug Development
Companies similar to Monument Therapeutics
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
vTv Therapeutics
Committed to Improving the Lives of Patients with Diabetes
High Point, United States
Track all Monument Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Cerebral Therapeutics, Inc.
A clinical stage pharmaceutical company developing innovative treatments for neurological...
Aurora, United States
SynapCell
Evaluate your most effective drug candidates in vivo using objective & translational measu...
Boston, France
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
BrainCells
Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS disorders...
CNS Therapeutics
Delivering advanced neurological and pain treatments with precision and expertise
Saint Paul, United States
Kynexis
Kynexis is advancing the first potential precision medicine for the treatment of CIAS.
Ariel Precision Medicine
Focused on transforming discoveries into treatments for chronic diseases with high unmet n...
Pittsburgh, United States
Neurolixis
New treatments for central nervous system disorders
Park Ridge, United States
About Monument Therapeutics
Monument Therapeutics, founded in 2019, is a forward-thinking biotechnology spin-out from Cambridge Cognition headquartered in the United Kingdom. The company positions itself at the intersection of health care and pharmaceutical industries with the goal of transforming neuroscience drug development through its slogan:...
Development of targeted treatments for neuroscience conditions, Identification of suitable patients using digital biomarkers, Clinical drug development
Patients with cognitive impairments linked to schizophrenia, Individuals with neuroinflammation, Healthcare providers in psychiatry and neurology fields
Precision Medicine, Neuroscience, Drug Development, Central Nervous System Disorders, Digital Biomarkers, Disease Sub-type Identification, Targeted Compounds, Pharmacogenomics, Spin-Out, UK-Based Company, Cambridge Cognition, Clinical Research, Neurobiology, Personalized Treatment
B2B, B2D
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Monument Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Monument Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
